201 related articles for article (PubMed ID: 28724911)
21. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
22. SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities.
Hong SW; Jung KH; Lee HS; Son MK; Yan HH; Kang NS; Lee J; Hong SS
Carcinogenesis; 2013 Sep; 34(9):2156-69. PubMed ID: 23671132
[TBL] [Abstract][Full Text] [Related]
23. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
[TBL] [Abstract][Full Text] [Related]
25. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
[TBL] [Abstract][Full Text] [Related]
26. Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression.
Datta D; Contreras AG; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
J Am Soc Nephrol; 2008 Dec; 19(12):2437-46. PubMed ID: 18832436
[TBL] [Abstract][Full Text] [Related]
27. Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia.
Zhou B; Li H; Xing C; Ye H; Feng J; Wu J; Lu Z; Fang J; Gao S
Biochem Pharmacol; 2017 Mar; 128():12-25. PubMed ID: 28043811
[TBL] [Abstract][Full Text] [Related]
28. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest.
Wolf I; O'Kelly J; Wakimoto N; Nguyen A; Amblard F; Karlan BY; Arbiser JL; Koeffler HP
Int J Oncol; 2007 Jun; 30(6):1529-37. PubMed ID: 17487375
[TBL] [Abstract][Full Text] [Related]
29. Novel Honokiol-eluting PLGA-based scaffold effectively restricts the growth of renal cancer cells.
Hamedani Y; Chakraborty S; Sabarwal A; Pal S; Bhowmick S; Balan M
PLoS One; 2020; 15(12):e0243837. PubMed ID: 33332399
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of Sp1 is involved in honokiol-induced cell cycle arrest and apoptosis in human malignant pleural mesothelioma cells.
Chae JI; Jeon YJ; Shim JH
Oncol Rep; 2013 Jun; 29(6):2318-24. PubMed ID: 23525508
[TBL] [Abstract][Full Text] [Related]
31. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
Liu SH; Wang KB; Lan KH; Lee WJ; Pan HC; Wu SM; Peng YC; Chen YC; Shen CC; Cheng HC; Liao KK; Sheu ML
PLoS One; 2012; 7(8):e43711. PubMed ID: 22937084
[TBL] [Abstract][Full Text] [Related]
32. [Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
Cheng Z; Xue F; Wang S; Wang F; Liang L; Bai P; Bian Y; Wan J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):143-6. PubMed ID: 24491053
[TBL] [Abstract][Full Text] [Related]
33. Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model.
Pan HC; Lai DW; Lan KH; Shen CC; Wu SM; Chiu CS; Wang KB; Sheu ML
Carcinogenesis; 2013 Nov; 34(11):2568-79. PubMed ID: 23828905
[TBL] [Abstract][Full Text] [Related]
34. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
35. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
Lv XQ; Qiao XR; Su L; Chen SZ
Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
[TBL] [Abstract][Full Text] [Related]
36. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
[TBL] [Abstract][Full Text] [Related]
37. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation.
Liu F; Zhang Y; Xia X; Han J; Cao L
J Obstet Gynaecol Res; 2024 Jun; 50(6):1010-1019. PubMed ID: 38576101
[TBL] [Abstract][Full Text] [Related]
38. Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway.
Zhang T; Xiang L
Cell Mol Biol Lett; 2019; 24():15. PubMed ID: 30833971
[TBL] [Abstract][Full Text] [Related]
39. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
Lee YS; Jeong S; Kim KY; Yoon JS; Kim S; Yoon KS; Ha J; Kang I; Choe W
Biochem Biophys Res Commun; 2021 May; 552():44-51. PubMed ID: 33743348
[TBL] [Abstract][Full Text] [Related]
40. Honokiol inhibits androgen receptor activity in prostate cancer cells.
Hahm ER; Karlsson AI; Bonner MY; Arbiser JL; Singh SV
Prostate; 2014 Apr; 74(4):408-20. PubMed ID: 24338950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
